Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
An erroneous concentration was used in the elecsys n-mid osteocalcin method sheet ( version 1.0) for cobas e801 under section "limitations-interference" where the potential interference of "endogenous substances" is listed. in the column "concentration tested" for hemoglobin "= 311 mmol/l" is written instead of the correct concentration of "= 0.311 mmol/l".